Professor John Chapman
Pitie Salpetriere APHP University Hospital, Paris (France)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dyslipidaemia management: a moving target!
Event: ESC Preventive Cardiology 2022
Topic: Lipids
Session type: Symposium
Add on to take back control: Combining lipid lowering therapies for the management of high risk patients
Event: ESC Congress 2020
Topic: Drug therapy
Session type: Industry Q&A session
Beyond statins - Evolving concepts for the management of dyslipidaemia
Event: ESC Congress 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
PCSK9i, changing practice in cardiology: the emerging story
Event: ESC Congress 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Meet the Trialists - HPS3/TIMI55-REVEAL
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session type: Meet the Trialists
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention
Event: ESC Congress 2017
Topic: Atherosclerosis
Session type: Satellite Symposium
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in cardiovascular disease prevention
Event: ESC Congress 2017
Topic: Atherosclerosis
Session type: Satellite Symposium
Triglycerides and cardiovascular risk: the importance of treating hypertriglyceridaemia
Event: ESC CONGRESS 2014
Topic: Primary cardiovascular prevention: interventions and outcomes
Session type: EBAC Accredited Educational Programme
ESC 365 is supported by
